Projected Income Statement: Silicon Laboratories Inc.

Forecast Balance Sheet: Silicon Laboratories Inc.

Fiscal Period: January 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -1,589 -662 -394 -382 -444 -482 -694 -828
Change - 58.34% 40.48% 3.05% -16.23% -8.65% -43.98% -19.31%
Announcement Date 2/2/22 2/1/23 2/7/24 2/4/25 2/4/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Silicon Laboratories Inc.

Fiscal Period: January 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 28.58 26.52 22.28 11.75 29.92 40.52 40.22
Change - -7.18% -16% -47.28% 154.7% 35.43% -0.74%
Free Cash Flow (FCF) 1 62.62 114.7 -52.63 -25.66 65.79 11 120.4
Change - 83.24% -145.87% 51.25% 356.4% -83.28% 994.55%
Announcement Date 2/2/22 2/1/23 2/7/24 2/4/25 2/4/26 - -
1USD in Million
Estimates

Forecast Financial Ratios: Silicon Laboratories Inc.

Fiscal Period: January 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 17.72% 23.14% 11.61% -9.21% 6.37% 15.7% 17.63% 15.94%
EBIT Margin (%) 15.21% 20.94% 8.33% -13.58% 3.22% 11.03% 15.16% 13.66%
EBT Margin (%) -8.07% 12.35% -1.35% -26.49% -7.38% -3.17% - -
Net margin (%) 293.73% 8.93% -4.41% -32.69% -8.27% -4.81% -0.1% -
FCF margin (%) 8.69% 11.2% -6.73% -4.39% 8.38% 1.19% 11.24% -
FCF / Net Income (%) 2.96% 125.54% 152.48% 13.43% -101.35% -24.74% -11,638.47% -

Profitability

        
ROA - - 2.99% -4.12% 2.44% 6.96% 10.9% -
ROE 8.02% 9.4% 4.13% -4.8% 2.79% 9.65% 12.34% 11.4%

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - - -
Debt / Free cash flow - - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 3.96% 2.59% 2.85% 2.01% 3.81% 4.39% 3.75% -
CAPEX / EBITDA (%) 22.38% 11.19% 24.53% -21.82% 59.82% 27.94% 21.29% -
CAPEX / FCF (%) 45.63% 23.12% -42.34% -45.79% 45.48% 368.4% 33.41% -

Items per share

        
Cash flow per share 1 - - - -0.4321 2.925 2.95 4.54 -
Change - - - - 776.93% 0.85% 53.9% -
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 57.49 43.91 37.89 33.55 33.45 35.64 37.62 45.36
Change - -23.62% -13.72% -11.45% -0.31% 6.55% 5.58% 20.56%
EPS 1 47.78 2.54 -1.09 -5.93 -1.98 -1.82 -0.03 -
Change - -94.68% -142.91% -444.04% 66.61% 8.08% 98.35% -
Nbr of stocks (in thousands) 40,187 33,283 31,779 32,448 32,853 32,982 32,982 32,982
Announcement Date 2/2/22 2/1/23 2/7/24 2/4/25 2/4/26 - - -
1USD
Estimates
2026 *2027 *
P/E -119x -7,249x
PBR 6.1x 5.78x
EV / Sales 7.24x 6.05x
Yield - -

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
217.47USD
Average target price
222.86USD
Spread / Average Target
+2.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SLAB Stock
  4. LA5 Stock
  5. Financials Silicon Laboratories Inc.